Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Crispr Therapeutics AG
(CRSP)
NASDAQ
:CRSP
CRSP
Crispr Therapeutics AG
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Crispr Therapeutics AG (CRSP) Stock News & Sentiment
Compare
Follow
10,767
Followers
Premium
Company Announcements
CRISPR Therapeutics Highlights Pipeline Advances in Gene-Edited Therapies
4d ago
8K
CRSP
Premium
Market News
Cathie Wood’s ARK Funds Had ‘One Heck of a Year’ — What’s Next for 2026?
12d ago
TEM
ARKF
Premium
Market News
Cathie Wood’s ARK Adds to CRISPR Stock — Here’s What Else It Traded This Week
18d ago
WRD
ACHR
Premium
Market News
Cathie Wood Adds to WeRide (WRD) and CRISPR, Trims Ibotta (IBTA) in Holiday Trades
21d ago
WRD
CRSP
Premium
Market News
Cathie Wood’s Christmas Trades: ARK Invest Bets on WeRide and CRISPR
23d ago
WRD
CRSP
Premium
Ratings
Early but Compelling CTX112 Data Underpin Buy Rating and $80 Target for CRISPR Therapeutics
24d ago
CRSP
Premium
Ratings
Buy Rating on CRISPR Therapeutics Driven by Promising zugo‑cel Data, Expanding Gene-Editing Pipeline, and Favorable Long-Term Risk–Reward Profile
24d ago
CRSP
More CRSP News >
CRSP News on the Web
All News
Bearish News
Bullish News
2026-01-13
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
Zacks
Neutral
2026-01-12
CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True?
Zacks
Neutral
2026-01-09
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade
Zacks
Neutral
2026-01-06
Three Genomics Stocks Worth Tracking This Year
Zacks
Neutral
2026-01-05
CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why
Zacks
Neutral
2026-01-04
Cathie Wood’s ARK Funds Had ‘One Heck of a Year’ — What’s Next for 2026?
TipRanks News
Neutral
2025-12-31
Can BEAM's Gene Editing Pipeline Create Long-Term Value Amid Rivalry?
Zacks
Neutral
2025-12-30
CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks
Neutral
150
Results | Showing
1
out of
19
News Score - Last 7 Days
Neutral
CRSP
Sector Average
Media Buzz
This Week
3 articles
Weekly Average
4.75 articles
News Sentiment
This Week
50%
Sector Average
58%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is CRSP’s Media Buzz Sentiment?
3 articles about CRSP were published this week. In an average week, 4.75 articles are published.
What is CRSP’s weekly average amount of articles?
In an average week, 4.75 articles about CRSP are published.
What is CRSP’s News Sentiment?
50% of articles about CRSP were positive this week, compared to its sector average of 58%.
Healthcare Stocks that are Trending in the News
KRYS
Krystal Biotech
WST
West Pharmaceutical Services
SEMHF
Siemens Healthineers AG
RPRX
Royalty Pharma
NYXH
Nyxoah
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.